Logo image of ILMN

ILLUMINA INC (ILMN) Stock Overview

NASDAQ:ILMN - US4523271090 - Common Stock

101.8 USD
+2.51 (+2.53%)
Last: 8/22/2025, 8:16:15 PM
102.65 USD
+0.85 (+0.83%)
After Hours: 8/22/2025, 8:16:15 PM

ILMN Key Statistics, Chart & Performance

Key Statistics
52 Week High156.66
52 Week Low68.7
Market Cap15.65B
Shares153.70M
Float153.38M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)4.16
PE24.47
Fwd PE21.43
Earnings (Next)11-03 2025-11-03/amc
IPO06-28 2000-06-28
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services


ILMN short term performance overview.The bars show the price performance of ILMN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20

ILMN long term performance overview.The bars show the price performance of ILMN in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of ILMN is 101.8 USD. In the past month the price decreased by -6.86%. In the past year, price decreased by -22.52%.

ILLUMINA INC / ILMN Daily stock chart

ILMN Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 22.84 188.80B
DHR DANAHER CORP 28.13 151.66B
A AGILENT TECHNOLOGIES INC 22.52 34.55B
IQV IQVIA HOLDINGS INC 16.67 32.50B
MTD METTLER-TOLEDO INTERNATIONAL 32.31 27.22B
WAT WATERS CORP 24.71 17.99B
WST WEST PHARMACEUTICAL SERVICES 35.61 17.82B
TEM TEMPUS AI INC N/A 13.99B
ICLR ICON PLC 13.29 13.67B
MEDP MEDPACE HOLDINGS INC 34.47 13.02B
RVTY REVVITY INC 19.25 10.93B
QGEN QIAGEN N.V. 21.17 10.77B

About ILMN

Company Profile

ILMN logo image Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.

Company Info

ILLUMINA INC

5200 Illumina Way

San Diego CALIFORNIA 92122 US

CEO: Francis A. deSouza

Employees: 9000

ILMN Company Website

ILMN Investor Relations

Phone: 18582024500

ILLUMINA INC / ILMN FAQ

What is the stock price of ILLUMINA INC today?

The current stock price of ILMN is 101.8 USD. The price increased by 2.53% in the last trading session.


What is the ticker symbol for ILLUMINA INC stock?

The exchange symbol of ILLUMINA INC is ILMN and it is listed on the Nasdaq exchange.


On which exchange is ILMN stock listed?

ILMN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ILLUMINA INC stock?

30 analysts have analysed ILMN and the average price target is 114.55 USD. This implies a price increase of 12.52% is expected in the next year compared to the current price of 101.8. Check the ILLUMINA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ILLUMINA INC worth?

ILLUMINA INC (ILMN) has a market capitalization of 15.65B USD. This makes ILMN a Large Cap stock.


How many employees does ILLUMINA INC have?

ILLUMINA INC (ILMN) currently has 9000 employees.


What are the support and resistance levels for ILLUMINA INC (ILMN) stock?

ILLUMINA INC (ILMN) has a support level at 98.15 and a resistance level at 104.78. Check the full technical report for a detailed analysis of ILMN support and resistance levels.


Is ILLUMINA INC (ILMN) expected to grow?

The Revenue of ILLUMINA INC (ILMN) is expected to decline by -2.11% in the next year. Check the estimates tab for more information on the ILMN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ILLUMINA INC (ILMN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ILLUMINA INC (ILMN) stock pay dividends?

ILMN does not pay a dividend.


When does ILLUMINA INC (ILMN) report earnings?

ILLUMINA INC (ILMN) will report earnings on 2025-11-03, after the market close.


What is the Price/Earnings (PE) ratio of ILLUMINA INC (ILMN)?

The PE ratio for ILLUMINA INC (ILMN) is 24.47. This is based on the reported non-GAAP earnings per share of 4.16 and the current share price of 101.8 USD. Check the full fundamental report for a full analysis of the valuation metrics for ILMN.


What is the Short Interest ratio of ILLUMINA INC (ILMN) stock?

The outstanding short interest for ILLUMINA INC (ILMN) is 4.89% of its float. Check the ownership tab for more information on the ILMN short interest.


ILMN Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to ILMN. When comparing the yearly performance of all stocks, ILMN turns out to be only a medium performer in the overall market: it outperformed 41.22% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ILMN Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to ILMN. ILMN has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ILMN Financial Highlights

Over the last trailing twelve months ILMN reported a non-GAAP Earnings per Share(EPS) of 4.16. The EPS increased by 352.17% compared to the year before.


Industry RankSector Rank
PM (TTM) 29.37%
ROA 20.67%
ROE 55.71%
Debt/Equity 0.66
Chartmill High Growth Momentum
EPS Q2Q%230.56%
Sales Q2Q%-4.77%
EPS 1Y (TTM)352.17%
Revenue 1Y (TTM)-3.27%

ILMN Forecast & Estimates

30 analysts have analysed ILMN and the average price target is 114.55 USD. This implies a price increase of 12.52% is expected in the next year compared to the current price of 101.8.

For the next year, analysts expect an EPS growth of 76.16% and a revenue growth -2.11% for ILMN


Analysts
Analysts72
Price Target114.55 (12.52%)
EPS Next Y76.16%
Revenue Next Year-2.11%

ILMN Ownership

Ownership
Inst Owners101.51%
Ins Owners0.17%
Short Float %4.89%
Short Ratio3.46